ELV Investors Have the Opportunity to Lead the Elevance Securities Fraud Lawsuit with Faruqi & Faruqi, LLPFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
CLASS ACTION REMINDER: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Inquire About a Securities Fraud Lawsuit by July 11, 2025PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the “Class Period”).
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELVNEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
ELV Class Action Lawsuit – Shareholders Should Contact Robbins LLP for Information About Leading the Class Action Against Elevance Health, Inc.SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of Elevance Health, Inc. (
NYSE: ELV) common stock between April 18, 2024 and October 16, 2024. Elevance is a healthcare company that, among other things, provides health insurance plans to a variety of markets.
ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLPFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELVNEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and West Pharmaceutical and Encourages Investors to Contact the FirmNEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Compass Diversified (
NYSE:CODI), Digimarc Corporation (
NASDAQ:DMRC), Elevance Health, Inc. (
NYSE:ELV), and West Pharmaceutical Services, Inc. (
NYSE:WST). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
INVESTOR REMINDER: Berger Montague Notifies Elevance Health (NYSE: ELV) Investors of a Class Action Lawsuit and DeadlinePHILADELPHIA, May 21, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the “Class Period”).
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP reminds investors of the upcoming July 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”).
Deadline Approaching: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming July 11, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”).
ELV INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that the Elevance Health class action lawsuit – captioned Miller v. Elevance Health, Inc., No. 25-cv-00923 (S.D. Ind.) – seeks to represent purchasers of Elevance Health, Inc. (
NYSE: ELV) common stock and charges Elevance Health as well as certain of Elevance Health’s executives with violations of the Securities Exchange Act of 1934.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELVNEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLPFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Elevance Health, Inc. (ELV) Investors To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”). Elevance investors have until July 11, 2025 to file a lead plaintiff motion.
ELEVANCE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Encourages Investors to Contact the FirmNEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE:ELV) in the United States District Court for the Southern District of Indiana on behalf of all persons and entities who purchased or otherwise acquired Elevance securities between April 18, 2024, and October 16, 2024, both dates inclusive (the “Class Period”). Investors have until July 11, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Elevance Health, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against ELVSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Elevance Health, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against ELVSAN DIEGO, CA - May 15, 2025 ( NEWMEDIAWIRE ) - Robbins LLP informs stockholders that a class action was filed on behalf of all purchasers of Elevance Health, Inc. (
NYSE: ELV) common stock between April 18, 2024 and October 16, 2024. Elevance is a healthcare company that, among other things, provides health insurance plans to a variety of markets.
Law Offices of Howard G. Smith Encourages Elevance Health, Inc. (ELV) Investors To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”). Elevance investors have until July 11, 2025 to file a lead plaintiff motion.
Law Offices of Frank R. Cruz Encourages Elevance Health, Inc. (ELV) Investors To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”). Elevance investors have until July 11, 2025 to file a lead plaintiff motion.
Securities Fraud Investigation Into Elevance Health, Inc. (ELV) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) investors concerning the Company’s possible violations of the federal securities laws.
Elevance Health, Inc. (ELV) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (
NYSE: ELV) investors concerning the Company’s possible violations of federal securities laws.
ELV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that the Elevance Health class action lawsuit – captioned Miller v. Elevance Health, Inc., No. 25-cv-00923 (S.D. Ind.) – seeks to represent purchasers of Elevance Health, Inc. (
NYSE: ELV) common stock and charges Elevance Health and certain of Elevance Health’s top executives with violations of the Securities Exchange Act of 1934.
